NorthWest Healthcare Properties Real Estate Investment Trust

NorthWest Healthcare Properties Real Estate Investment Trust

NWH-UN.TO
NorthWest Healthcare Properties Real Estate Investment TrustCA flagToronto Stock Exchange
5.66
CAD
-0.01
- -
1.41BMarket Cap
NorthWest Healthcare Properties Real Estate Investment Trust
NWH-UN.TO
(Toronto Stock Exchange)

Recent

price

5.66

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
2.31
3.35
3.49
3.87
1.13
3.78
3.99
3.11
3.38
2.38
2.12
1.67
1.88
2.09
1.87
- -
1.7
Revenue per Share
0.04
2.22
2.4
0.94
-0.68
2.22
0.82
0.67
0.63
-0.01
1.79
1.94
0.27
-1.43
-1.21
- -
-0.21
Basic EPS, GAAP
0.66
-5.63
1
1.15
0.23
0.88
1.42
0.88
0.9
0.83
1.07
0.56
0.95
0.43
0.35
- -
0.6
Free Cash Flow per Basic Share
- -
0.68
0.69
0.73
0.54
0.55
0.64
0.62
0.72
0.56
0.74
0.61
0.64
0.61
0.32
- -
0.31
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
9.32
9.24
10.12
11.8
11.36
9.24
7.59
- -
6.95
Book Value per Share
9.14
11.12
12.87
13
2.24
14.32
15.05
14.58
15
12.94
13.9
15.32
15.2
12.34
10.08
- -
6.05
Tangible Book Value per Share
28
35
38
39
39
53
69
101
104
154
176
224
241
243
248
- -
249
Basic Weighted Avg Shares
65
118
134
150
44
199
277
314
350
366
374
375
452
508
462
423
423
Sales/Revenue/Turnover
22.84
54.57
54.76
54.31
78.06
60.74
66.68
68.37
69.48
69.95
71.7
71.21
70.03
67.8
67.1
64.02
64.02
Operating Margin (%)
20
- -
- -
- -
2
- -
1
1
1
2
2
1
1
1
4
- -
3
Depreciation Expense
1
78
92
37
-27
117
57
67
66
-2
314
435
64
-348
-300
-53
-53
Net Income, GAAP
- -
- -
- -
- -
- -
16.36
29.63
18.51
36.1
54.64
3.74
16.88
38.7
- -
- -
22.22
22.22
Effective Tax Rate (%)
1.62
66.31
68.79
24.33
-60.52
58.73
20.54
21.46
18.8
-0.51
84.09
116.09
14.22
-68.44
-64.83
-12.51
-12.51
Profit Margin (%)
45
-10
-14
-17
-1
-9
-91
27
-251
104
-390
-609
-9
-457
-334
-296
-296
Working Capital
372
508
661
699
460
1,423
1,629
2,284
2,536
2,594
2,342
2,308
3,174
3,471
2,462
885
885
LT Debt
330
396
500
509
100
843
1,190
1,655
1,683
2,076
2,536
3,524
3,742
3,085
2,582
1,507
1,507
Total Equity
- -
8.03
7.13
6.88
- -
7.13
5.03
5.01
3.61
2.49
5.07
3.75
2.79
- -
- -
4.96
4.96
Return on Invested Capital (%)
- -
23.14
20.63
9.97
- -
7.38
2.3
-0.17
2.47
-0.37
6.68
4.78
1.43
- -
- -
-0.49
-0.49
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
13.62
-0.16
19.65
19.66
2.39
-13.96
-14.52
-2.92
-2.92
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Jun'25
Sep'25
Dec'25
ST Debt
564
522
486
LT Borrowings
2,293
2,367
874
LT Finance Leases
21
21
10
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
249
250
250
Market Capitalization
1,236
1,269
1,273

Working Capital

FRC

in mil. unless spec.
Jun'25
Sep'25
Dec'25
Total Current Assets
165
204
507
Cash, Cash Equivalents & STI
80
77
94
Accounts Receivable, Net
18
12
4
Inventories
- -
- -
- -
Total Current Liabilities
705
655
803
Payables & Accruals
129
119
84
ST Debt
564
522
486
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.71%
-6.07%
-41.63%
Free Cash Flow
24.31%
10.18%
73.88%
Net Income, GAAP
-1,782.35%
-156.76%
-82.37%
Sales/Revenue/Turnover
8.64%
3.13%
-8.62%
Total Cash Common Dividend
14.42%
-6.9%
-1.79%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
135
127
122
124
508
2024
134
119
107
103
462
2025
112
99
104
108
423

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
-0.4
-0.13
-0.33
- -
-1.43
2024
-0.19
-0.5
-0.56
- -
-1.21
2025
- -
0.1
0.06
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
0.16
0.16
0.2
- -
0.61
2024
0.08
0.08
0.08
- -
0.32
2025
0.08
0.08
0.08
- -
- -
Business
NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) is a Canadian open-ended real estate investment trust that owns, manages and develops a diversified portfolio of high-quality international healthcare real estate infrastructure; the portfolio, comprising 167 income-producing properties totaling approximately 15.8 million square feet of gross leasable area as of mid-2025, includes core infrastructure hospitals, specialty hospitals, outpatient and ambulatory care centres, multi-tenant medical office buildings, rehabilitation centres, specialty clinics, aged care facilities, and properties focused on research, education and life sciences, with tenants primarily consisting of leading hospital operators and healthcare practitioners supported by government funding. The REIT operates in major urban markets across Canada, the United States, Brazil, Germany, the Netherlands, Australia and New Zealand, delivering stable income through long-term indexed leases and high occupancy rates. Founded in 2004 and publicly listed on the Toronto Stock Exchange since 2010, it maintains headquarters in Toronto, Ontario, and employs over 210 professionals across seven countries to execute value-add partnerships with healthcare operators. In recent strategic developments, the REIT completed the sale of 46 properties and unlisted securities for $1.6 billion in proceeds primarily used for debt repayment as part of its 2023-initiated strategic review process, which concluded with the divestiture of its UK portfolio in 2024; it extended leases on six UK hospitals in May 2024, increasing maturities from nine to 25 years while securing a $1.7 million surrender fee and new tenancy. In November 2025, NorthWest reached a conditional agreement to internalize management rights of Vital Healthcare Property Trust for NZ$214 million ($170 million) in cash, subject to lender consents, regulatory approvals and Vital's NZ$175 million equity raise, enabling deleveraging and a reallocation of capital toward North American growth while retaining a 24% stake in Vital; additionally, its second-largest tenant Healthscope Pty Ltd repaid all deferred rents plus interest by October 2025 amid a receiver-led sale process, with operations continuing uninterrupted. These moves reflect ongoing portfolio optimization, NOI growth from inflationary rent adjustments, and fair value gains of $8.8 million in Q3 2025.